Yes on ice until all the SEC requirements are satisfied for listing without the IPO part, February is the planned listing month!
To coincide with the sleep apnoea results for maximum impact - exposure and price appreciation.
Then the BOD will be able to at a point in time into the future to raise extra capital via an IPO but that could change in preference to bonus option issues as already mentioned, supporting existing shareholders instead of all the risks of prevailing market uncertainties.
Looking forward now to our listing on the Nasdaq without further dilution in February sometime
